Participant flow

A Phase II Study of Doxycycline in Relapsed NHL · Source last updated 2016-12-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Doxycycline 200 mg twice daily Doxycycline

   id

   FG000

   title

   Doxycycline

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Adverse Event

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Withdrawal by Subject

   3. reasons

      1. group Id

         FG000

         num Subjects

         3

      type

      protocol terminated

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         7

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         2

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         5

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice